位置:首页 > 蛋白库 > PA2HP_PROMU
PA2HP_PROMU
ID   PA2HP_PROMU             Reviewed;         138 AA.
AC   Q2PWA3;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   25-MAY-2022, entry version 62.
DE   RecName: Full=Basic phospholipase A2 homolog promutoxin {ECO:0000303|PubMed:16793192};
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Protobothrops mucrosquamatus (Taiwan habu) (Trimeresurus mucrosquamatus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Protobothrops.
OX   NCBI_TaxID=103944;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-46, FUNCTION, SUBUNIT,
RP   MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=16793192; DOI=10.1016/j.biochi.2006.05.003;
RA   Wei J.-F., Li T., Wei X.-L., Sun Q.-Y., Yang F.-M., Chen Q.-Y., Wang W.-Y.,
RA   Xiong Y.-L., He S.-H.;
RT   "Purification, characterization and cytokine release function of a novel
RT   Arg-49 phospholipase A(2) from the venom of Protobothrops mucrosquamatus.";
RL   Biochimie 88:1331-1342(2006).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic
CC       activity. Exhibits potent myotoxicity causing myonecrosis and edema in
CC       the gastrocnemius muscle of mice (PubMed:16793192). Is also able to
CC       stimulate the release of IL12 (IL12A-IL12B), TNF-alpha (TNF), IL6 and
CC       IL1-beta (IL1B) from human monocytes, and induce IL2, TNFalpha and IL6
CC       release from T-cells (PubMed:16793192). A model of myotoxic mechanism
CC       has been proposed: an apo Lys49-PLA2 is activated by the entrance of a
CC       hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of
CC       the protein leading to a reorientation of a monomer (By similarity).
CC       This reorientation causes a transition between 'inactive' to 'active'
CC       states, causing alignment of C-terminal and membrane-docking sites
CC       (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in
CC       the same plane, exposed to solvent and in a symmetric position for both
CC       monomers (By similarity). The MDoS region stabilizes the toxin on
CC       membrane by the interaction of charged residues with phospholipid head
CC       groups (By similarity). Subsequently, the MDiS region destabilizes the
CC       membrane with penetration of hydrophobic residues (By similarity). This
CC       insertion causes a disorganization of the membrane, allowing an
CC       uncontrolled influx of ions (i.e. calcium and sodium), and eventually
CC       triggering irreversible intracellular alterations and cell death (By
CC       similarity). {ECO:0000250|UniProtKB:I6L8L6,
CC       ECO:0000269|PubMed:16793192}.
CC   -!- SUBUNIT: Homodimer; non-covalently linked.
CC       {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:16793192}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:16793192}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:16793192}.
CC   -!- MASS SPECTROMETRY: Mass=13656; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:16793192};
CC   -!- MISCELLANEOUS: Fails to induce platelet aggregation, and has little
CC       effect on the ADP-induced platelet aggregation. Does not show
CC       hemorrhagic activity (PubMed:16793192). {ECO:0000305|PubMed:16793192}.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II subfamily.
CC       R49 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding sites is
CC       lost (Asp->Arg in position 64, which corresponds to 'Arg-49' in the
CC       current nomenclature). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ299948; ABC02868.1; -; mRNA.
DR   AlphaFoldDB; Q2PWA3; -.
DR   SMR; Q2PWA3; -.
DR   PRIDE; Q2PWA3; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Myotoxin; Secreted; Signal;
KW   Toxin.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:16793192"
FT   CHAIN           17..138
FT                   /note="Basic phospholipase A2 homolog promutoxin"
FT                   /id="PRO_0000419213"
FT   REGION          122..133
FT                   /note="Important for membrane-damaging activities in
FT                   eukaryotes and bacteria; heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   SITE            122
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            125
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            128
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            129
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            131
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   DISULFID        42..132
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        44..60
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        59..112
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        65..138
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        66..105
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        73..98
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   DISULFID        91..103
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
SQ   SEQUENCE   138 AA;  15443 MW;  C218367908B7F140 CRC64;
     MRTLWIMAVL LLGVEGSVIE LGKMVFQETG KNPVKNYGLY GCNCGVGKRG KPVDATDSCC
     FVHRCCYKKV TGCDPKKDRY SYSWENKAIV CGEKNPPCLK QVCECDKAVA ICLRENLGTY
     DKKHRVTMKF LCKAPESC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024